Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Post-stroke depression, affecting approximately one-third of stroke survivors, is driven by ischemia-induced M1 microglial polarization, NLRP3 inflammasome activation via NF-kappaB signaling, and blood-brain barrier disruption amplifying peripheral cytokine access to peri-infarct tissue [12].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [12]
In the citing paper
“Kivimäki and colleagues, analyzing data from the Whitehall II cohort, found that elevated interleukin-6 concentrations measured in midlife significantly predicted the onset of depression over the subsequent decade [12, 22].”
From Neuroinflammation and depression: immune-brain interface mechanisms, biomarker stratification, and therapeutic strategies (2026) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
Hammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225 · cited 1×
“The ischemia stimuli after ischemic stroke induce the microglia activation, afterwards, microglia undergo physical and biochemical changes, including cell migration, phagocytosis, cell proliferation, and production of cytokines [89].”
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · cited 1×
“The polarization of M2 microglia is characterized by the increased expressions of anti-inflammatory factors, containing TGF-β, IL-10 and IL-4 [104].”
Neurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060 · cited 1×
“BDNF is essential for the differentiation of neural stem cells (NSCs), and promote neuronal growth and maturation [118, 119].”
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · cited 1×
“Whereas, A2 astrocytes produce brain-derived neurotrophic factor (BDNF), which is known as neurotrophic factor and provide neuroprotection against cerebral ischemia injury [115-117].”
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 1×
“2) As the resident immune cells in the CNS, microglia constantly monitor the surrounding microenvironment [88].”
Ayerbe, L., Ayis, S., Wolfe, C. D. A., & Rudd, A. G. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107664 · Cited by 980 · cited 2×
“39% to 52% of stroke patients have at least one episode of depression within 5 years after stroke [5].”
BDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958 · cited 2×
“Not surprisingly, BDNF depletion can abolish the protective effects of antidepressants [161].”
Research works printed but not linked: 135
- Gaete JM, Bogousslavsky J (2008). Post-stroke depression. Expert Rev Neurother, 8:75-92. · DOI · Paper page
- Staub F, Bogousslavsky J (2001). Post-stroke depression or fatigue. Eur Neurol, 45:3-5. · DOI
- Paolucci S, Iosa M, Coiro P, Venturiero V, Savo A, De Angelis D, et al. (2019). Post-stroke Depression Increases Disability More Than 15% in Ischemic Stroke Survivors: A Case-Control Study. Front Neurol, 10:926. · DOI
- Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, et al. (2013). Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke. Cerebrovasc Dis, 36:336-343. · DOI
- Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, et al. (2012). Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med, 16:1961-1969. · DOI · Paper page
- Fan Q, Liu Y, Sheng L, Lv S, Yang L, Zhang Z, et al. (2023). Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3beta/PTEN/Akt pathway. Biomed Pharmacother, 160:114385. · DOI
- Kliper E, Bashat DB, Bornstein NM, Shenhar-Tsarfaty S, Hallevi H, Auriel E, et al. (2013). Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Stroke, 44:1433-1435. · DOI
- Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. (2003). An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol, 139:93-101. · DOI · Paper page
- Chen H, Liu F, Sun D, Zhang J, Luo S, Liao Q, et al. (2022). The potential risk factors of early-onset post-stroke depression from immuno-inflammatory perspective. Front Immunol, 13:1000631. · DOI
- Hadidi N, Treat-Jacobson DJ, Lindquist R (2009). Poststroke depression and functional outcome: a critical review of literature. Heart Lung, 38:151-162. · DOI · Paper page
- Gaupp R, Berrios GE, Pomarol-Clotet E (2000). Depressive states in old age. (Classic Text No. 42). Hist Psychiatry, 11:213-225. · DOI
- Roth M (1955). The natural history of mental disorder in old age. J Ment Sci, 101:281-301. · DOI · Paper page
- Folstein MF, Maiberger R, McHugh PR (1977). Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry, 40:1018-1020. · DOI · Paper page
- Chen H, Huang X, Zeng C, Sun D, Liu F, Zhang J, et al. (2023). The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression. Front Immunol, 14:1125634. · DOI
- Robinson RG, Kubos KL, Starr LB, Rao K, Price TR (1984). Mood disorders in stroke patients. Importance of location of lesion. Brain, 107(Pt 1):81-93. · DOI · Paper page
- Spitzer RL, Kroenke K, Williams JB (1999). Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA, 282:1737-1744. · DOI · Paper page
- Medeiros GC, Roy D, Kontos N, Beach SR (2020). Post-stroke depression: A 2020 updated review. Gen Hosp Psychiatry, 66:70-80. · DOI · Paper page
- Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H (1986). Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke, 17:1102-1107. · DOI · Paper page
- Baccaro A, Wang YP, Brunoni AR, Candido M, Conforto AB, da Costa Leite C, et al. (2019). Does stroke laterality predict major depression and cognitive impairment after stroke? Two-year prospective evaluation in the EMMA study. Prog Neuropsychopharmacol Biol Psychiatry, 94:109639. · DOI
- Bekhbat M, Neigh GN (2018). Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety. Brain Behav Immun, 67:1-12. · DOI · Paper page
- Starkstein SE, Robinson RG, Price TR (1987). Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain, 110(Pt 4):1045-1059. · DOI · Paper page
- Kim JS, Choi-Kwon S (2000). Poststroke depression and emotional incontinence: correlation with lesion location. Neurology, 54:1805-1810. · DOI · Paper page
- Morris PL, Robinson RG, Raphael B, Hopwood MJ (1996). Lesion location and poststroke depression. J Neuropsychiatry Clin Neurosci, 8:399-403. · DOI · Paper page
- Klingbeil J, Brandt ML, Wawrzyniak M, Stockert A, Schneider HR, Baum P, et al. (2021). Association of Lesion Location and Depressive Symptoms Poststroke. Stroke, 52:830-837. · DOI
- Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, et al. (2007). Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. Eur Arch Psychiatry Clin Neurosci, 257:149-152. · DOI
- Terroni L, Amaro E, Iosifescu DV, Tinone G, Sato JR, Leite CC, et al. (2011). Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study. World J Biol Psychiatry, 12:539-548. · DOI
- Liang W, Fan Z, Cui S, Shen X, Wang L (2021). The association between White matter microstructure alterations detected by Diffusional kurtosis imaging in Neural circuit and post-stroke depression. Neurol Res, 43:535-542. · DOI
- Lu Y, Liang H, Han D, Mo Y, Li Z, Cheng Y, et al. (2016). The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder. Neuroimage Clin, 11:658-666. · DOI · Paper page
- Dihne M, Grommes C, Lutzenburg M, Witte OW, Block F (2002). Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke, 33:3006-3011. · DOI · Paper page
- Santos M, Kovari E, Gold G, Bozikas VP, Hof PR, Bouras C, et al. (2009). The neuroanatomical model of post-stroke depression: towards a change of focus? J Neurol Sci, 283:158-162. · DOI
- Narushima K, Kosier JT, Robinson RG (2003). A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci, 15:422-430. · doi:10.1176/jnp.15.4.422 · Paper page
- Guo J, Wang J, Sun W, Liu X (2022). The advances of post-stroke depression: 2021 update. J Neurol, 269:1236-1249. · DOI · Paper page
- Karaahmet OZ, Gurcay E, Avluk OC, Umay EK, Gundogdu I, Ecerkale O, et al. (2017). Poststroke depression: risk factors and potential effects on functional recovery. Int J Rehabil Res, 40:71-75. · DOI
- Leonard B, Maes M (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev, 36:764-785. · DOI · Paper page
- Oglodek E (2022). Changes in the Serum Levels of Cytokines: IL-1beta, IL-4, IL-8 and IL-10 in Depression with and without Posttraumatic Stress Disorder. Brain Sci, 12. · DOI
- Wang L, Wang R, Liu L, Qiao D, Baldwin DS, Hou R (2019). Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis. Brain Behav Immun, 79:24-38. · DOI · Paper page
- Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG (2006). The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry, 11:984-991. · DOI · Paper page
- Li R, Fan W, Li D, Liu X (2022). Correlation of common inflammatory cytokines with cognition impairment, anxiety, and depression in acute ischemic stroke patients. Braz J Med Biol Res, 55:e11517. · DOI
- Chamorro A, Dirnagl U, Urra X, Planas AM (2016). Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol, 15:869-881. · DOI · Paper page
- Shichita T, Ito M, Yoshimura A (2014). Post-ischemic inflammation regulates neural damage and protection. Front Cell Neurosci, 8:319. · DOI · Paper page
- Spalletta G, Cravello L, Imperiale F, Salani F, Bossu P, Picchetto L, et al. (2013). Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci, 25:255-263. · DOI · Paper page
- Hannestad J, DellaGioia N, Bloch M (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology, 36:2452-2459. · DOI · Paper page
- Kim JM, Stewart R, Kim SW, Shin IS, Kim JT, Park MS, et al. (2012). Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry, 13:579-587. · DOI · Paper page
- Yang L, Zhang Z, Sun D, Xu Z, Zhang X, Li L (2010). The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res, 32:340-346. · DOI · Paper page
- Bossu P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F, et al. (2009). Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res, 6:163-170. · DOI · Paper page
- Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M (1999). Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity, 10:127-136. · DOI · Paper page
- Kuwahara-Otani S, Maeda S, Kobayashi K, Minato Y, Tanaka K, Yamanishi K, et al. (2017). Interleukin-18 and its receptor are expressed in gonadotropin-releasing hormone neurons of mouse and rat forebrain. Neurosci Lett, 650:33-37. · DOI
- Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H (2002). Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci, 22:5910-5919. · DOI · Paper page
- Jander S, Schroeter M, Stoll G (2002). Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J Cereb Blood Flow Metab, 22:62-70. · DOI
- Russell JM (2000). Sodium-potassium-chloride cotransport. Physiol Rev, 80:211-276. · DOI · Paper page
- Goubert E, Altvater M, Rovira MN, Khalilov I, Mazzarino M, Sebastiani A, et al. (2019). Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior. Front Mol Neurosci, 12:12. · DOI
- Tsukahara T, Masuhara M, Iwai H, Sonomura T, Sato T (2015). Repeated stress-induced expression pattern alterations of the hippocampal chloride transporters KCC2 and NKCC1 associated with behavioral abnormalities in female mice. Biochem Biophys Res Commun, 465:145-151. · DOI
- Li Z, Xu H, Xu Y, Lu G, Peng Q, Chen J, et al. (2021). Morinda officinalis oligosaccharides alleviate depressive-like behaviors in post-stroke rats via suppressing NLRP3 inflammasome to inhibit hippocampal inflammation. CNS Neurosci Ther, 27:1570-1586. · DOI
- Su JA, Chou SY, Tsai CS, Hung TH (2012). Cytokine changes in the pathophysiology of poststroke depression. Gen Hosp Psychiatry, 34:35-39. · DOI
- Korostynski M, Hoinkis D, Piechota M, Golda S, Pera J, Slowik A, et al. (2021). Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms. Transl Psychiatry, 11:246. · DOI
- Ting EY, Yang AC, Tsai SJ (2020). Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci, 21. · DOI · Paper page
- Girotti M, Donegan JJ, Morilak DA (2013). Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology, 38:1158-1169. · DOI · Paper page
- Anderson G, Kubera M, Duda W, Lason W, Berk M, Maes M (2013). Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep, 65:1647-1654. · DOI · Paper page
- Euteneuer F, Dannehl K, Del Rey A, Engler H, Schedlowski M, Rief W (2017). Peripheral Immune Alterations in Major Depression: The Role of Subtypes and Pathogenetic Characteristics. Front Psychiatry, 8:250. · DOI · Paper page
- Langhein M, Seitz-Holland J, Lyall AE, Pasternak O, Chunga N, Cetin-Karayumak S, et al. (2022). Association between peripheral inflammation and free-water imaging in Major Depressive Disorder before and after ketamine treatment - A pilot study. J Affect Disord, 314:78-85. · DOI
- Protti GG, Gagliardi RJ, Forte WC, Sprovieri SR (2013). Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke. Arq Neuropsiquiatr, 71:846-851. · DOI
- Laumet G, Edralin JD, Chiang AC, Dantzer R, Heijnen CJ, Kavelaars A (2018). Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology, 43:2597-2605. · DOI
- Turner CA, Thompson RC, Bunney WE, Schatzberg AF, Barchas JD, Myers RM, et al. (2014). Altered choroid plexus gene expression in major depressive disorder. Front Hum Neurosci, 8:238. · DOI · Paper page
- Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, et al. (2011). Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. J Affect Disord, 134:217-225. · DOI
- Kim JM, Kang HJ, Kim JW, Bae KY, Kim SW, Kim JT, et al. (2017). Associations of Tumor Necrosis Factor-alpha and Interleukin-1beta Levels and Polymorphisms with Post-Stroke Depression. Am J Geriatr Psychiatry, 25:1300-1308. · DOI
- Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, et al. (2014). Kynurenine and depressive symptoms in a poststroke population. Neuropsychiatr Dis Treat, 10:1827-1835. · DOI
- Levada OA, Troyan AS (2018). Poststroke Depression Biomarkers: A Narrative Review. Front Neurol, 9:577. · DOI · Paper page
- Waller R, Baxter L, Fillingham DJ, Coelho S, Pozo JM, Mozumder M, et al. (2019). Iba-1-/CD68+ microglia are a prominent feature of age-associated deep subcortical white matter lesions. PLoS One, 14:e0210888. · DOI · Paper page
- Boche D, Perry VH, Nicoll JA (2013). Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol, 39:3-18. · DOI · Paper page
- Wang J, Xing H, Wan L, Jiang X, Wang C, Wu Y (2018). Treatment targets for M2 microglia polarization in ischemic stroke. Biomed Pharmacother, 105:518-525. · DOI · Paper page
- He C, Liu R, Fan Z, Li Y, Yang M, Wugang H, et al. (2021). Microglia in the Pathophysiology of Hemorrhagic Stroke and the Relationship Between Microglia and Pain After Stroke: A Narrative Review. Pain Ther, 10:927-939. · DOI
- Li Q, Dai Z, Cao Y, Wang L (2019). Caspase-1 inhibition mediates neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-kappaB activation. Biochem Biophys Res Commun, 513:479-485. · DOI
- Yang L, Tucker D, Dong Y, Wu C, Lu Y, Li Y, et al. (2018). Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells. Exp Neurol, 299:86-96. · DOI · Paper page
- Nakagawa Y, Chiba K (2014). Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel), 7:1028-1048. · DOI · Paper page
- Roesch S, Rapp C, Dettling S, Herold-Mende C (2018). When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma. Int J Mol Sci, 19. · DOI · Paper page
- Chu F, Shi M, Zheng C, Shen D, Zhu J, Zheng X, et al. (2018). The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol, 318:1-7. · DOI · Paper page
- Dos Santos IRC, Dias MNC, Gomes-Leal W (2021). Microglial activation and adult neurogenesis after brain stroke. Neural Regen Res, 16:456-459. · DOI
- Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, et al. (2019). Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis, 10:487. · DOI · Paper page
- Sharma M, Arbabzada N, Flood PM (2019). Mechanism underlying beta2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells. J Neuroimmunol, 332:37-48. · DOI
- Zhang L, Previn R, Lu L, Liao RF, Jin Y, Wang RK (2018). Crocin, a natural product attenuates lipopolysaccharide-induced anxiety and depressive-like behaviors through suppressing NF-kB and NLRP3 signaling pathway. Brain Res Bull, 142:352-359. · DOI · Paper page
- Chen T, Li Z, Li S, Zou Y, Gao X, Shu S, et al. (2022). Cycloastragenol suppresses M1 and promotes M2 polarization in LPS-stimulated BV-2 cells and ischemic stroke mice. Int Immunopharmacol, 113:109290. · DOI
- Hsu CH, Pan YJ, Zheng YT, Lo RY, Yang FY (2023). Ultrasound reduces inflammation by modulating M1/M2 polarization of microglia through STAT1/STAT6/PPARgamma signaling pathways. CNS Neurosci Ther. · DOI
- Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, Robicsek SA, et al. (2017). Role of Interleukin-10 in Acute Brain Injuries. Front Neurol, 8:244. · DOI · Paper page
- Xia CY, Zhang S, Gao Y, Wang ZZ, Chen NH (2015). Selective modulation of microglia polarization to M2 phenotype for stroke treatment. Int Immunopharmacol, 25:377-382. · DOI · Paper page
- Zhang Y, Yu P, Liu H, Yao H, Yao S, Yuan SY, et al. (2019). Hyperforin improves post-stroke social isolation-induced exaggeration of PSD and PSA via TGF-beta. Int J Mol Med, 43:413-425. · DOI
- Wei L, Guo J, Yu X, Chen H, Du Y, Ji Z, et al. (2021). Role and characteristics of hippocampal region microglial activation in poststroke depression. J Affect Disord, 291:270-278. · DOI
- Scarisbrick IA, Radulovic M, Burda JE, Larson N, Blaber SI, Giannini C, et al. (2012). Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. Biol Chem, 393:355-367. · DOI
- Herx LM, Yong VW (2001). Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol, 60:961-971. · DOI · Paper page
- Ponath G, Ramanan S, Mubarak M, Housley W, Lee S, Sahinkaya FR, et al. (2017). Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology. Brain, 140:399-413. · DOI · Paper page
- Morizawa YM, Hirayama Y, Ohno N, Shibata S, Shigetomi E, Sui Y, et al. (2017). Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat Commun, 8:28. · DOI · Paper page
- Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. (2016). Schizophrenia risk from complex variation of complement component 4. Nature, 530:177-183. · DOI · Paper page
- Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H (2010). When neurogenesis encounters aging and disease. Trends Neurosci, 33:569-579. · DOI · Paper page
- O'Leary LA, Belliveau C, Davoli MA, Ma JC, Tanti A, Turecki G, et al. (2021). Widespread Decrease of Cerebral Vimentin-Immunoreactive Astrocytes in Depressed Suicides. Front Psychiatry, 12:640963. · DOI
- Rajkowska G, Legutko B, Moulana M, Syed M, Romero DG, Stockmeier CA, et al. (2018). Astrocyte pathology in the ventral prefrontal white matter in depression. J Psychiatr Res, 102:150-158. · DOI · Paper page
- Tural U, Irvin MK, Iosifescu DV (2022). Correlation between S100B and severity of depression in MDD: A meta-analysis. World J Biol Psychiatry, 23:456-463. · DOI
- Hidese S, Hattori K, Sasayama D, Tsumagari T, Miyakawa T, Matsumura R, et al. (2020). Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study. Transl Psychiatry, 10:161. · DOI
- Zhang L, Verwer RWH, Zhao J, Huitinga I, Lucassen PJ, Swaab DF (2021). Changes in glial gene expression in the prefrontal cortex in relation to major depressive disorder, suicide and psychotic features. J Affect Disord, 295:893-903. · DOI · Paper page
- Zhao YF, Verkhratsky A, Tang Y, Illes P (2022). Astrocytes and major depression: The purinergic avenue. Neuropharmacology, 220:109252. · DOI
- Peng L, Verkhratsky A, Gu L, Li B (2015). Targeting astrocytes in major depression. Expert Rev Neurother, 15:1299-1306. · DOI · Paper page
- Yao S, Xu MD, Wang Y, Zhao ST, Wang J, Chen GF, et al. (2023). Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice. Nat Commun, 14:729. · DOI
- Liu J, Mo JW, Wang X, An Z, Zhang S, Zhang CY, et al. (2022). Astrocyte dysfunction drives abnormal resting-state functional connectivity in depression. Sci Adv, 8:eabo2098. · DOI
- Gao HQ, Zhu HY, Zhang YQ, Wang LX (2008). Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: A preliminary report. Clin Invest Med, 31:E351-356. · DOI
- Zhao Q, Guo Y, Yang D, Yang T, Meng X (2016). Serotonin Transporter Gene 5-HTTLPR Polymorphism as a Protective Factor Against the Progression of Post-Stroke Depression. Mol Neurobiol, 53:1699-1705. · DOI
- Legg LA, Rudberg AS, Hua X, Wu S, Hackett ML, Tilney R, et al. (2021). Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev, 11:CD009286. · DOI
- Villa RF, Ferrari F, Moretti A (2018). Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacol Ther, 184:131-144. · DOI · Paper page
- Zhang J, Ning L, Wang J (2020). Dietary quercetin attenuates depressive-like behaviors by inhibiting astrocyte reactivation in response to stress. Biochem Biophys Res Commun, 533:1338-1346. · DOI
- Shiroyama T, Fukuyama K, Okada M (2021). Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43. Int J Mol Sci, 22. · DOI
- Chen B, Zhang M, Ji M, Gong W, Chen B, Zorec R, et al. (2021). The Association Between Antidepressant Effect of SSRIs and Astrocytes: Conceptual Overview and Meta-analysis of the Literature. Neurochem Res, 46:2731-2745. · DOI
- Fang Y, Ding X, Zhang Y, Cai L, Ge Y, Ma K, et al. (2022). Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT(2B)R/beta-arrestin2 pathway. J Neuroinflammation, 19:23. · DOI · Paper page
- Fang Y, Guo H, Wang Q, Liu C, Ge S, Yan B (2022). The role and mechanism of NLRP3 inflammasome-mediated astrocyte activation in dehydrocorydaline against CUMS-induced depression. Front Pharmacol, 13:1008249. · DOI
- Bauer ME, Teixeira AL (2019). Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci, 1437:57-67. · DOI · Paper page
- Cheng SY, Zhao YD, Li J, Chen XY, Wang RD, Zeng JW (2014). Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology, 47:126-135. · DOI
- Zhao A, Ma B, Xu L, Yao M, Zhang Y, Xue B, et al. (2021). Jiedu Tongluo Granules Ameliorates Post-stroke Depression Rat Model via Regulating NMDAR/BDNF Signaling Pathway. Front Pharmacol, 12:662003. · DOI
- Frank D, Kuts R, Tsenter P, Gruenbaum BF, Grinshpun Y, Zvenigorodsky V, et al. (2019). The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach. Neuropharmacology, 155:173-184. · DOI
- Gruenbaum BF, Kutz R, Zlotnik A, Boyko M (2020). Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression. Ther Adv Psychopharmacol, 10:2045125320903951. · DOI
- Rappeneau V, Blaker A, Petro JR, Yamamoto BK, Shimamoto A (2016). Disruption of the Glutamate-Glutamine Cycle Involving Astrocytes in an Animal Model of Depression for Males and Females. Front Behav Neurosci, 10:231. · DOI
- Yu D, Cheng Z, Ali AI, Wang J, Le K, Chibaatar E, et al. (2019). Down-expressed GLT-1 in PSD astrocytes inhibits synaptic formation of NSC-derived neurons in vitro. Cell Cycle, 18:105-114. · DOI
- Martinez-Lozada Z, Guillem AM, Robinson MB (2016). Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors. Adv Pharmacol, 76:103-145. · DOI
- Jiang MQ, Yu SP, Wei ZZ, Zhong W, Cao W, Gu X, et al. (2021). Conversion of Reactive Astrocytes to Induced Neurons Enhances Neuronal Repair and Functional Recovery After Ischemic Stroke. Front Aging Neurosci, 13:612856. · DOI
- Li J, Zhao YD, Zeng JW, Chen XY, Wang RD, Cheng SY (2014). Serum Brain-derived neurotrophic factor levels in post-stroke depression. J Affect Disord, 168:373-379. · DOI
- Xu HB, Xu YH, He Y, Xue F, Wei J, Zhang H, et al. (2018). Decreased Serum Brain-Derived Neurotrophic Factor May Indicate the Development of Poststroke Depression in Patients with Acute Ischemic Stroke: A Meta-Analysis. J Stroke Cerebrovasc Dis, 27:709-715. · DOI
- Noonan K, Carey LM, Crewther SG (2013). Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke. J Stroke Cerebrovasc Dis, 22:e124-135. · DOI
- Zha Z, Liu YJ, Liu SS, Zhang N, Li JL, Qi F, et al. (2022). Bu Shen Yi Sui Capsule Promotes Myelin Repair by Modulating the Transformation of A1/A2 Reactive Astrocytes In Vivo and In Vitro. Oxid Med Cell Longev, 2022:3800004. · DOI
- Zhang C, Wang X, Zhu Q, Mei Y, Zhang Z, Xu H (2022). Decreased Serum Brain-Derived Neurotrophic Factor in Poststroke Depression: A Systematic Review and Meta-Analysis. Front Psychiatry, 13:876557. · DOI
- Shan D, Zheng Y, Froud K (2021). Brain-Derived Neurotrophic Factor as a Clinical Biomarker in Predicting the Development of Post-Stroke Depression: A Review of Evidence. Cureus, 13:e15662. · DOI
- Liang J, Yue Y, Jiang H, Geng D, Wang J, Lu J, et al. (2018). Genetic variations in the p11/tPA/BDNF pathway are associated with post stroke depression. J Affect Disord, 226:313-325. · DOI
- Lee BH, Kim YK (2010). The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig, 7:231-235. · DOI · Paper page
- Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci, 22:3251-3261. · DOI · Paper page
- Chen HH, Zhang N, Li WY, Fang MR, Zhang H, Fang YS, et al. (2015). Overexpression of brain-derived neurotrophic factor in the hippocampus protects against post-stroke depression. Neural Regen Res, 10:1427-1432. · DOI
- Shah ZA, Sharma P, Vohora SB (2003). Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels. Eur Neuropsychopharmacol, 13:321-325. · DOI
- Kumar U, Medel-Matus JS, Redwine HM, Shin D, Hensler JG, Sankar R, et al. (2016). Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy. Epilepsia, 57:506-515. · DOI
- Lavergne F, Jay TM (2010). A new strategy for antidepressant prescription. Front Neurosci, 4:192. · DOI
- Skirzewski M, Karavanova I, Shamir A, Erben L, Garcia-Olivares J, Shin JH, et al. (2018). ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors. Mol Psychiatry, 23:2227-2237. · DOI · Paper page
- Liu Y, Ishida Y, Shinoda K, Nakamura S (2003). Interaction between serotonergic and noradrenergic axons during axonal regeneration. Exp Neurol, 184:169-178. · DOI
- Zahrai A, Vahid-Ansari F, Daigle M, Albert PR (2020). Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression. Transl Psychiatry, 10:334. · DOI
Cited by
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04255-4
Metadata
- Authors
- Lu, W., & Wen, J.
- Venue
- Aging and disease
- Publisher
- Aging and Disease
- Published
- 2025
- Volume
- 16
- Issue
- 1
- Pages
- 394
- ISSN
- 2152-5250
- Cited by
- 54
- References
- 33
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes. https://app.cochat.ai/papers/10.14336/ad.2024.0214-1
- The paper
- Lu, W., & Wen, J. (2025). Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes. Aging and disease. https://doi.org/10.14336/ad.2024.0214-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.